Reuters -- Takeda Pharmaceutical, Japan's largest drugmaker, said on Friday it is set to start an additional clinical study on a key diabetes drug candidate next month, setting a timeline that could see it receive U.S. approval in 2012.
Reuters -- Takeda Pharmaceutical, Japan's largest drugmaker, said on Friday it is set to start an additional clinical study on a key diabetes drug candidate next month, setting a timeline that could see it receive U.S. approval in 2012.
